Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Islet Transplantation with Belatacept in Type 1 Diabetes
NCT00468403Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2008
- Primary completion
- Apr 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of belatacept in type 1 diabetes mellitus (T1D), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2008; status: completed.
02
Drugs
belatacept
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00468403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468403.